Evidencia científica

Granulocyte/monocyte adsorptive apheresis for the treatment of therapy-refractory chronic active ulcerative colitis

Axel Dignass 1Ayesha Akbar 2Daniel C Baumgart 3Gilles Bommelaer 4Guillaume Bouguen 5Guillaume Cadiot 6Anton Gillessen 7Jean-Charles Grimaud 8Ailsa Hart 2Syed Hoque 9Richard Makins 10Christophe Michiels 11Jacques Moreau 12Purushothaman Premchand 13Wolfgang Ramlow 14Stefan Schanz 15Sreedhar Subramanian 16Christian von Tirpitz 17Bruno Bonaz 18 , Scand J Gastroenterol. 2018 Apr;53(4):442-448.

This study confirms findings of the 12-week interim analysis and demonstrates that GMA apheresis provides a safe and beneficial long-term outcome for patients with chronic active UC resistant/intolerant to IS and/or TNF inhibitors.

https://pubmed.ncbi.nlm.nih.gov/29513111/

ContáctanosPara solicitar información adicional

Contáctanos